Simultaneous quantification of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
Walter J Loos, Anne-Joy M de Graan, Peter de Bruijn, Ron H N van Schaik, Marianne A C van Fessem, Mei-Ho Lam, Ron H J Mathijssen, Erik A C Wiemer
文献索引:J. Pharm. Biomed. Anal. 54(2) , 387-94, (2011)
全文:HTML全文
摘要
A rapid and sensitive ultra performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS) method has been developed and validated for the simultaneous quantitative determination of dextromethorphan (DM) and its metabolites dextrorphan (DX), 3-methoxymorphinan (3MM) and 3-hydroxymorphinan (3HM), in human lithium heparinized plasma. The extraction involved a simple liquid-liquid extraction with 1 ml n-butylchloride from 200μl aliquots of plasma, after the addition of 20 μl 4% (v/v) ammonium hydroxide and 100 μl stable labeled isotopic internal standards in acetonitrile. Chromatographic separations were achieved on an Aquity UPLC(®) BEH C(18) 1.7 μm 2.1 mm x 100mm column eluted at a flow-rate of 0.250 ml/min on a gradient of acetonitrile. The overall cycle time of the method was 7 min, with elution times of 1.3min for DX and 3HM, 2.8 min for 3MM and 2.9min for DM. The multiple reaction monitoring transitions were set at 272>215 (m/z), at 258>133 (m/z), at 258>213 (m/z) and at 244>157 (m/z) for DM, DX, 3MM and 3HM, respectively. The calibration curves were linear (r²≥0.995) over the range of 0.500-100 nM with the lower limit of quantitation validated at 0.500 nM for all compounds, which is equivalent to 136, 129, 129 and 122 pg/ml for DM, DX, 3MM and 3HM, respectively. Extraction recoveries were constant, but ranged from 39% for DM to 83% for DX. The within-run and between-run precisions were within 11.6%, while the accuracy ranged from 92.7 to 110.6%. The applicability of the bioanalytical method was demonstrated and is currently implemented in a clinical trial to study DM as probe-drug for individualized tamoxifen treatment in breast cancer patients.Copyright © 2010 Elsevier B.V. All rights reserved.
相关化合物
相关文献:
2015-01-01
[Xenobiotica 45(1) , 29-44, (2014)]
2014-06-01
[Food Chem. Toxicol. 68 , 117-27, (2014)]
2014-04-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 957 , 36-40, (2014)]
2014-08-01
[Anal. Bioanal. Chem 406(20) , 4875-87, (2014)]
1999-09-24
[Anal. Bioanal. Chem 406(18) , 4453-64, (2014)]